Cargando…
Down’s syndrome and COVID-19: risk or protection factor against infection? A molecular and genetic approach
Down syndrome (DS) is the most common genetic cause of learning difficulties and intellectual disabilities. DS patients often present with several congenital defects and chronic diseases, including immunity disorders. Elevated levels of pro-inflammatory cytokines such as interleukin (IL)-6 and tumor...
Autores principales: | Altable, Marcos, de la Serna, Juan Moisés |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683327/ https://www.ncbi.nlm.nih.gov/pubmed/33231770 http://dx.doi.org/10.1007/s10072-020-04880-x |
Ejemplares similares
-
Protection against COVID-19 in African population: Immunology, genetics, and malaria clues for therapeutic targets
por: Altable, Marcos, et al.
Publicado: (2021) -
COVID-19 infection and Down syndrome—challenges and future directions for care in children
por: Chauhan, Kaushambi, et al.
Publicado: (2022) -
COVID-19 in patients with Down syndrome
por: Emami, Amir, et al.
Publicado: (2021) -
Sound prescriptions to mitigate the effects of COVID-19 in the population with Down syndrome
por: Verd, Sergio, et al.
Publicado: (2021) -
Down syndrome: the aggravation of COVID-19 may be partially justified by the expression of TMPRSS2
por: Evangelho, Victor Gustavo Oliveira, et al.
Publicado: (2021)